The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.
Case Report of Novel Variant in Patient With PAH Highlights Benefit of Genetic Testing
April 22nd 2023Subsequent testing revealed the presence of the variant in the patient’s siblings, also underscoring the importance of counseling family members who have pulmonary arterial hypertension (PAH).
Read More
PEA Leads to Long-term QOL Improvement in People With CTEPH, Study Suggests
April 17th 2023Most patients with chronic thromboembolic pulmonary hypertension (CTEPH) said they can go about their daily activities without restriction, the authors found, because of gains in functional status and quality of life (QOL).
Read More
Patients With PAH Accrue Higher Costs, HRU, Regardless of Etiology
April 10th 2023Patients with pulmonary arterial hypertension (PAH) related to connective tissue disorders (CTDs) and patients with PAH related to another condition accrued higher costs and higher health care resource use (HRU) vs patients who had CTD without PH.
Read More
Study Underscores Need for Optimal RV Function Measures in PH
March 18th 2023Right ventricular (RV) dysfunction has previously been linked to symptoms and mortality in pulmonary hypertension (PH), as well as in other conditions, and RV function plays an important role in disease risk and potentially in intensification of pulmonary arterial hypertension treatment.
Read More
Noninvasive Predictors of Pulmonary Hypertension in Interstitial Lung Disease Identified
March 11th 2023The researchers noted that their study is the first to assess the ability of noninvasive variables, both resting- and exercise-based, to identify pulmonary hypertension in interstitial lung disease.
Read More
Impaired Exercise Capacity From PAH-CHD Most Prominent in Patients With Eisenmenger Syndrome
February 25th 2023Study findings offer insight into how exercise intolerance varies among subgroups of pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as previous data have characterized impaired exercise tolerance among PAH-CHD as a whole.
Read More
Novel Machine Learning Model May Detect Pulmonary Hypertension Earlier
February 24th 2023Having a diagnostic model that leverages artificial intelligence could fill a gap in the pulmonary hypertension (PH) diagnostic pathway, as there are currently just 2 validated screening algorithms for PH.
Read More
Nationwide Data Show Delayed Correct Diagnosis for PAH
February 6th 2023The long time to diagnosis is consistent with data pointing to pulmonary arterial hypertension (PAH) often being misdiagnosed as asthma, said the researchers, adding that the findings from their retrospective study provide valuable insight into where the diagnostic pathway lags.
Read More
Fetal Outcomes, Maternal Mortality Vary Among Pregnant Women With Different Types of PH
January 19th 2023A small study conducted in China suggests pregnant women with idiopathic pulmonary arterial hypertension (iPAH) are at higher risk of maternal mortality compared with women with certain other types of pulmonary hypertension (PH).
Read More
Contraction, Mortality Rate of COVID-19 Was Lower in Vaccinated Patients With PAH
January 9th 2023Patients with pulmonary arterial hypertension (PAH) were more likely to die or be hospitalized if they contracted COVID-19 but were less likely to die from COVID-19 if they were vaccinated against SARS-CoV-2.
Read More
Hypertension Knowledge, Training Lacking Within Internal Medicine Programs
November 17th 2022Despite the commonality of hypertension among US adults—nearly half of them have elevated blood pressure—hypertension education among internal residents has not kept up with the condition’s prevalence.
Read More
Macitentan Safety, Effectiveness in PAH Confirmed in New Analysis
November 3rd 2022Two data sets from patients with severe pulmonary arterial hypertension (PAH) show the benefits of macitentan (Opsumit) monotherapy despite guidelines calling for combination therapy, even among patients with World Health Organizational functional class I-II disease.
Read More
Potential Risk Factors Identified for RRT Among Patients With PH
October 24th 2022According to the study authors, acute decompensated pulmonary hypertension (PH) is often accompanied by systemic congestion and right ventricular flow output, and because PH can be accompanied by acute kidney injury, renal replacement therapy (RRT) may be necessary.
Read More
Syncope May Increase Vasoreactivity Among Pediatric Patients With PAH
October 19th 2022Although group 1 pulmonary arterial hypertension (PAH) with comorbid syncope has been linked to a poor prognosis among adults, this relationship remains uncertain in pediatric patients, prompting a new study.
Read More
Sepsis, Septic Shock Likely Increase Risk of Adverse Outcomes in PAH
October 11th 2022Investigators for this study analyzed outcomes among patients hospitalized with pulmonary arterial hypertension (PAH) who have higher risks of adverse health outcomes, in particular sepsis and septic shock.
Read More
Potential for PHC Necessitates Pediatric Cardiology Care for Children With PAH
September 28th 2022Outcomes following right heart catheterization in a pediatric patient population were analyzed, with emphasis placed on risk of adverse outcomes following the procedure, especially the development of pulmonary hypertensive crisis (PHC).
Read More
Potential for Precision Medicine Approach in PAH Explored in New Study
September 16th 2022This new study of pulmonary arterial hypertension (PAH) among women examined the in-common symptoms of different disease phenotypes to see where they overlap and ultimately to define the “symptome” according to symptom cluster and characteristics.
Read More
Mortality Worsens Following Borderline PH Diagnosis Among Patients With LHF
September 8th 2022Following a recent update to the diagnostic criteria for borderline pulmonary hypertension (PH), which is often associated with left heart failure (LHF), outcomes among patients with both conditions remain uncertain.
Read More